Evidence map›Paper›PMID 33407321›Full record

ArticleBMC public health2021

Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo.

Arnold J Sadio, Fifonsi A Gbeasor-Komlanvi, Rodion Y Konu, Akila W Bakoubayi, Martin K Tchankoni, Alexandra M Bitty-Anderson, Iris M Gomez, Claudia P Denadou, Joël Anani, Harold R Kouanfack and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 4 pooled it
23.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 4 syntheses or guidelines pooled it, 202 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Prescription-only medicine requests by clients: Insights from community pharmacies.Exploratory research in clinical and social pharmacy · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. A Qualitative Study of the Experience of COVID-19 Patients in Burkina Faso.The American journal of tropical medicine and hygiene · 2024
    Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Arnold J SadioDépartement de Santé Publique, Université de Lomé, Faculté des Sciences de la Santé, Lomé, Togo.
Fifonsi A Gbeasor-KomlanviDépartement de Santé Publique, Université de Lomé, Faculté des Sciences de la Santé, Lomé, Togo.
Rodion Y KonuDépartement de Santé Publique, Université de Lomé, Faculté des Sciences de la Santé, Lomé, Togo.
Akila W BakoubayiCentre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Lomé, Togo.
Martin K TchankoniCentre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Lomé, Togo.
Alexandra M Bitty-AndersonProgramme PACCI - Site ANRS Côte d'Ivoire, CHU de Treichville, Abidjan, Côte d'Ivoire.
Iris M GomezCentre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Lomé, Togo.
Claudia P DenadouCentre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Lomé, Togo.
Joël AnaniCentre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Lomé, Togo.
Harold R KouanfackCentre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Lomé, Togo.
Innocent K KpetoConseil Scientifique pour la riposte à la pandémie Covid-19, Lomé, Togo.
Mounerou SalouConseil Scientifique pour la riposte à la pandémie Covid-19, Lomé, Togo.
Didier K EkoueviDépartement de Santé Publique, Université de Lomé, Faculté des Sciences de la Santé, Lomé, Togo. didier.ekouevi@gmail.com.ORCID 0000-0001-7644-9902
Centre Africain de Recherche en Epidémiologie et en Santé Publique · TGProgramme PAC-CI · CIUniversité de Bordeaux · FRUniversity of Lomé · TG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo date, there is no effective treatment for COVID-19, which is a pandemic disease, caused by a novel coronavirus called SARS-CoV-2. In Togo, where four in five people practice self-medication, the absence of a cure for COVID-19 and the constant progression of the disease requires an assessment of self-medication patterns in the context of the pandemic. This study aimed to estimate the prevalence of self-medication to prevent COVID-19 and its associated factors in Lomé, Togo.

methodsA cross-sectional study was conducted in Lomé, the capital city of Togo, from April 23rd to May 8th, 2020, with a sample of participants from five sectors: the healthcare, air transport, police, road transport and informal sectors. The participants were invited to provide information about their self-medication practices to prevent COVID-19 in the 2 weeks preceding the survey.

resultsA total of 955 participants (71.6% men) with a median age of 36 (IQR 32-43) were included. Approximately 22.1% were in the air transport sector, 20.5% were in the police sector, and 38.7% were in the health sector. The overall prevalence of self-medication to prevent COVID-19 was 34.2% (95% CI: 31.2-37.3%). The most commonly used products were vitamin C (27.6%) and traditional medicine (10.2%). Only 2.0% of participants reported using chloroquine/hydroxychloroquine. Female sex (aOR=1.90; p< 0.001), work in the health sector (aOR=1.89; p= 0.001), secondary education level (aOR= 2.28; p= 0.043) and university education level (aOR= 5.11; p< 0.001) were associated with self-medication.

conclusionOne-third of the individuals in high-risk populations in Lomé practiced self-medication. Intensifying awareness campaigns is crucial to fight misinformation about alleged COVID-19 prevention products on social media.

Indexed as

Disease OutbreaksAdultCOVID-19Cross-Sectional StudiesFemaleHumansMaleSelf MedicationTogoCOVID-19Lomé-TogoPreventionSARS-CoV-2Self-medicationTraditional medicine

Identifiers

PMID33407321
PMCPMC7787400
OpenAlexW3112285942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.